Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: A methodological overview of statistical practice in randomized controlled clinical trials

Vaccine

Volumn 25, Issue 33, 2007, Pages 6237-6244

  Jahn Eimermacher, Antje ^a   du Prel, Jean Baptist ^a   Schmitt, Heinz Josef ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Pneumococcal vaccination; Statistical analysis; Vaccine efficacy

Indexed keywords

ANTIBIOTIC AGENT; HEPATITIS A VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VACCINATION;

CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 34447650427     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.062     Document Type: Article

References (36)

1. Darrow D.H., Dash N., and Derkay C.S. Otitis media: concepts and controversies. Curr Opin Otolaryngol Head Neck Surg 11 6 (2003) 416-423
2. Hoberman A., Marchant C.D., Kaplan S.L., and Feldman S. Treatment of acute otitis media consensus recommendations. Clin Pediatr 41 6 (2002) 373-390
3. Guven M., Bulut Y., Sezer T., Aladag I., Eyibilen A., and Etikan I. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin. Int J Pediatr Otorhinolaryngol 70 (2006) 915-923
4. Feldman H.M., Dollaghan C.A., Campbell T.F., Colborn D.K., Janosky J., Kurs-Lasky M., et al. Parent-reported language skills in relation to otitis media during the first 3 years of life. J Speech Lang Hear Res 46 2 (2003) 273-287
5. Kaplan B., Wandstrat T.L., and Cunningham J.R. Overall cost in the treatment of otitis media. Pediatr Infect Dis J 16 Suppl. 2 (1997) S9-S11
6. Straetemans M, Sanders EAM, Veenhoven RH, Schilder AGM, Damoiseaux RAMJ, Zielhuis GA. Pneumococcal vaccines for preventing otitis media (review). The Cochrane Collaboration, http://www.thecochranelibrary.com; 2006 [accessed July 21, 2006].
7. Makela P.H., Leinonen M., Pukander J., and Karma P. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media. Rev Infect Dis 3 Suppl. (1981) S124-S132
8. Sloyer Jr. J.L., Ploussard J.H., and Howie V.M. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama. Rev Infect Dis 3 Suppl. (1981) S119-S123
9. Teele D.W., Klein J.O., Bratton L., Fisch G.R., Mathieu O.R., Porter P.J., et al. Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. Rev Infect Dis 3 (1981) S113-S118
10. Schuller D.E. Prophylaxis of otitis media in asthmatic children. Pediatr Infect Dis 2 4 (1983) 280-283
11. Douglas R.M. Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. J Infect Dis 149 6 (1984) 861-869
12. Rosen C., Christensen P., Henrichsen J., Hovelius B., and Prellner K. Beneficial effect of pneumococcal vaccination on otitis media in children over two years old. Int J Pediatr Otorhinolaryngol 7 3 (1984) 239-246
13. Karma P., Pukander J., Sipila M., Timonen M., Pontynen S., Herva E., et al. Prevention of otitis media in children by pneumococcal vaccination. Am J Otolaryngol 6 3 (1985) 173-184
14. Douglas R.M., Hansman D., McDonald B., Paton J., and Kirke K. Pneumococcal vaccine in aboriginal children-a randomized controlled trial involving 60 children. Community Health Stud 10 2 (1986) 189-196
15. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19 3 (2000) 187-195
16. Eskola J., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 6 (2001) 403-409
17. Dagan R., Sikuler-Cohen M., Zamir O., Janco J., Givon-Lavi N., and Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 20 10 (2001) 951-958
18. Veenhoven R., Bogaert D., Uiterwaal C., Brouwer C., Kiezebrink H., Bruin J., et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361 9376 (2003) 2189-2195
19. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 9512 (2006) 740-748
20. Katz A., Leibovitz E., Greenberg D., Raiz S., Greenwald-Maimon M., Leiberman A., et al. Acute mastoiditis in Southern Israel: a twelve year retrospective study (1990 through 2001). Pediatr Infect Dis J 22 10 (2003) 878-882
21. Mahe C., and Chevret S. Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint. Stat Med 18 (1999) 1821-1829
22. Fireman B., Black S.B., Shinefield H.R., Lee J., Lewis E., and Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22 1 (2003) 10-16
23. Neto J.F.L., Hemb L., and e Silva D.B. Systematic literature review of modifiable risk factors for recurrent acute otitis media in childhood. J Pediatr (Rio J) 82 2 (2006) 87-96
24. Breslow N. Tests of hypotheses in overdispersed Poisson regression and other quasi-likelihood models. J Am Stat Assoc 85 410 (1990) 565-571
25. Thomsen J.L., and Parner E.T. Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Fam Pract 23 4 (2006) 407-413
26. Andersen P.K., and Gill R.D. Cox regression model for counting processes: a large sample study. Ann Stat 10 (1982) 1100-1120
27. Kelly P.J., and Lim L.L. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med 19 1 (2000) 13-33
28. Metcalfe C., and Thompson S.G. The importance of varying the event generation process in simulation studies of statistical methods for recurrent events. Stat Med 25 1 (2006) 165-179
29. Lin D.Y., and Wei L.J. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84 (1989) 1074-1078
30. Therneau T.M., and Grambsch P.M. Modeling Survival Data (2000), Springer-Verlag, New York
31. Kilpi T., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 9 (2003) 1155-1164
32. van Kempen M.J., Vermeiren J.S., Vaneechoutte M., Claeys G., Veenhoven R.H., Rijkers G.T., et al. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?. Int J Pediatr Otorhinolaryngol 70 2 (2006) 275-285
33. Prentice R.L., Williams B.J., and Peterson A.V. On the regression analysis of multivariate failure time data. Biometrika 68 (1981) 373-389
34. Wei L.J., Lin D.Y., and Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 84 (1989) 1065-1073
35. Windeler J., and Lange S. Events per person year-a dubious concept. BMJ 310 6977 (1995) 454-456
36. Halloran M.E., Haber M., Longini Jr. I.M., and Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 133 4 (1991) 323-331